Skip to main navigation
Skip to search
Skip to main content
Scholars @ UT Health San Antonio Home
Help & FAQ
English
Español
Home
Profiles
Research units
Publications
Datasets
Search by expertise, name or affiliation
Results of phase 3 of the CATIE schizophrenia trial
T. Scott Stroup
, Jeffrey A. Lieberman
, Joseph P. McEvoy
, Sonia M. Davis
, Marvin S. Swartz
, Richard S.E. Keefe
, Alexander L. Miller
, Robert A. Rosenheck
, John K. Hsiao
Department of Psychiatry & Behavioral Sciences
Research output
:
Contribution to journal
›
Article
›
peer-review
132
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Results of phase 3 of the CATIE schizophrenia trial'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Neuroscience
Antipsychotic
70%
Clozapine
30%
Fluphenazine
30%
Decanoic Acid
30%
Dementia Praecox
20%
Ziprasidone
20%
Aripiprazole
20%
Perphenazine
20%
Body Mass Index
10%
Quetiapine
10%
Olanzapine
10%
Risperidone
10%
Pharmacology, Toxicology and Pharmaceutical Science
Clozapine
30%
Fluphenazine Decanoate
30%
Symptom
30%
Schizophrenia
20%
Ziprasidone
20%
Perphenazine
20%
Aripiprazole
20%
Monotherapy
10%
Side Effect
10%
Health Status
10%
Olanzapine
10%
Risperidone
10%
Quetiapine
10%
Effectiveness Study
10%
Psychology
Treatment
100%
Schizophrenia
20%
Groups
20%
Body Mass Index
10%
Physical Health
10%